What is the latest news on ADRO?

Quantisnow has not tracked any new filings, ratings or press releases for ADRO in the last 30 days. The most recent wire item was published on November 27, 2020.

Where does ADRO stock trade?

Aduro Biotech, Inc. (ADRO) is listed on NASDAQ.

What sector and industry is ADRO in?

Aduro Biotech, Inc. operates in the Health Care sector, Major Pharmaceuticals industry.

When did Aduro Biotech, Inc. go public?

Aduro Biotech, Inc. (ADRO) completed its IPO in 2015.

What companies are similar to ADRO?

Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.), AKCA (Akcea Therapeutics, Inc.). Compare ADRO side-by-side with any of them on Quantisnow.

How can I track ADRO on Quantisnow?

Quantisnow aggregates Aduro Biotech, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ADRO to receive live email and push alerts on every new disclosure.

ADRO

NASDAQ

Aduro Biotech, Inc.

SectorHealth Care IndustryMajor PharmaceuticalsIPO2015

Follow + get alerts

Aduro Biotech, Inc. (ADRO) is a Major Pharmaceuticals company listed on NASDAQ. There were no new wire items for ADRO in the last 30 days. The most recent was published Nov 27, 2020.

Latest news

1 item

2170dPR
North America Cancer Vaccines Market Research Report 2020-2027
Dublin, Nov. 27, 2020 (GLOBE NEWSWIRE) -- The "North America Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology; Type; Indication; End User, and Country" report has been added to ResearchAndMarkets.com's offering. Cancer Vaccines Market for Dendritic Cells Cancer Vaccines Segment to Grow at Fastest CAGR during Forecast PeriodThe market is expected to reach US$6,626.6 million in 2027 from US$1,875.7 million in 2019; it is estimated to grow at a CAGR of 17.5% from 2020 to 2027. Based on technology, the Cancer Vaccines market is segmented into in dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cance

ADRO FAQ

6 questions

What is the latest news on ADRO?
Quantisnow has not tracked any new filings, ratings or press releases for ADRO in the last 30 days. The most recent wire item was published on November 27, 2020.
Where does ADRO stock trade?
Aduro Biotech, Inc. (ADRO) is listed on NASDAQ.
What sector and industry is ADRO in?
Aduro Biotech, Inc. operates in the Health Care sector, Major Pharmaceuticals industry.
When did Aduro Biotech, Inc. go public?
Aduro Biotech, Inc. (ADRO) completed its IPO in 2015.
What companies are similar to ADRO?
Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.), AKCA (Akcea Therapeutics, Inc.). Compare ADRO side-by-side with any of them on Quantisnow.
How can I track ADRO on Quantisnow?
Quantisnow aggregates Aduro Biotech, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ADRO to receive live email and push alerts on every new disclosure.